- Investing Ideas
- Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth
Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth
Results
3
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
3 companies
Square Pharmaceuticals
Market Cap: ৳194.0b
Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳218.80
7D
-0.2%
1Y
-1.1%
Beximco Pharmaceuticals
Market Cap: ৳65.6b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally.
BXPHARMA
৳146.50
7D
-0.9%
1Y
14.5%
Renata
Market Cap: ৳53.6b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh and Portugal.
RENATA
৳466.10
7D
-1.2%
1Y
-3.6%